DHL Supply Chain launches new Pharma Hub to bolster healthcare logistics in Singapore

In Singapore on April 14, 2025, DHL Supply Chain officially launched its new Pharma Hub, a dedicated facility for pharmaceutical logistics. This hub, which spans over 36,000 square meters, is part of the DHL Group's broader effort to invest €500 million into the Asia Pacific region's Life Sciences and Healthcare infrastructure. The new facility aims to meet the increasing demands for transformative healthcare solutions spurred by longer lifespans and rising consumer expectations. Eunis Hew, the Managing Director of DHL Supply Chain Singapore, highlighted Singapore's ambition to lead globally in life sciences and medtech innovation, emphasizing the hub's role in strengthening the company’s operations in the LSHC sector. The initiative corresponds with DHL Group's Strategy 2030, which focuses on expanding their healthcare capabilities. With this strategic move, the company reinforces its commitment to support various pharmaceutical and medical device clients while also addressing the complexities and regulatory challenges of the industry. The messaging around this investment also reflects a proactive approach by DHL Supply Chain to respond to evolving sector demands. The new Pharma Hub will serve as a critical regional distribution center and will facilitate operations for multiple multinational medical device companies. Prior to this announcement, DHL made significant investments in the region, including €28 million in upgrades to automation and robotics in Australia and the establishment of upcoming sites in South Korea aimed at meeting critical time-sensitive medical deliveries. For DHL Supply Chain, having extensive facilities compliant with Good Distribution Practice (GDP)/GMP is essential, ensuring the integrity and safety of sensitive products like pharmaceuticals. Innovation and efficiency remain key pillars of DHL’s strategy in the healthcare logistics space. The deployment of Control Tower technology provides real-time visibility across the supply chain while predictive analytics help in identifying risks and enhancing decision-making processes. As the company continues to advance its operations and technology, it remains focused on fostering collaboration among researchers, manufacturers, and medical experts. Ultimately, this cohesive network is designed to enhance the logistical capabilities necessary to support the healthcare sector effectively.